Therefore, we first evaluated the effect of LASS2 on the TFRC protein level in multiple tumour cell lines with or without treatment with a ferroptosis inhibitor (Fer-1) treatment or a ferroptosis agonist (erastin). This evidence concerns the gene TFRC and neoplasm.